These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2405389)

  • 1. The regulatory mechanisms of human immunodeficiency virus replication predict multiple expression rates.
    Palsson BO; Keasling JD; Emerson SG
    Proc Natl Acad Sci U S A; 1990 Jan; 87(2):772-6. PubMed ID: 2405389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of expression of human immunodeficiency virus.
    Pavlakis GN; Felber BK
    New Biol; 1990 Jan; 2(1):20-31. PubMed ID: 2078551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components.
    Likhoshvai VA; Khlebodarova TM; Bazhan SI; Gainova IA; Chereshnev VA; Bocharov GA
    BMC Genomics; 2014; 15 Suppl 12(Suppl 12):S1. PubMed ID: 25564443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tat transactivation of the human immunodeficiency virus type 1 promoter is influenced by basal promoter activity and the simian virus 40 origin of DNA replication.
    Kessler M; Mathews MB
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10018-22. PubMed ID: 1658792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
    Lisziewicz J; Sun D; Smythe J; Lusso P; Lori F; Louie A; Markham P; Rossi J; Reitz M; Gallo RC
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8000-4. PubMed ID: 8367455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust growth of human immunodeficiency virus type 1 (HIV-1).
    Kim H; Yin J
    Biophys J; 2005 Oct; 89(4):2210-21. PubMed ID: 16055539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
    Chang LJ; Zhang C
    Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional activation in vitro by the human immunodeficiency virus type 1 Tat protein: evidence for specific interaction with a coactivator(s).
    Song CZ; Loewenstein PM; Green M
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9357-61. PubMed ID: 7937769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tat's seductive side.
    Stevenson M
    Nat Med; 2003 Feb; 9(2):163-4. PubMed ID: 12563332
    [No Abstract]   [Full Text] [Related]  

  • 10. Arginine methylation of the human immunodeficiency virus type 1 Tat protein by PRMT6 negatively affects Tat Interactions with both cyclin T1 and the Tat transactivation region.
    Xie B; Invernizzi CF; Richard S; Wainberg MA
    J Virol; 2007 Apr; 81(8):4226-34. PubMed ID: 17267505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biology of HIV-1: positive and negative regulatory elements important for virus expression.
    Felber BK; Pavlakis GN
    AIDS; 1993; 7 Suppl 1():S51-62. PubMed ID: 8363803
    [No Abstract]   [Full Text] [Related]  

  • 12. Modulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5.
    Ping YH; Chu CY; Cao H; Jacque JM; Stevenson M; Rana TM
    Retrovirology; 2004 Dec; 1():46. PubMed ID: 15620346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tackling Tat.
    Karn J
    J Mol Biol; 1999 Oct; 293(2):235-54. PubMed ID: 10550206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the small leader exons 2 and 3 on human immunodeficiency virus type 1 gene expression.
    Krummheuer J; Lenz C; Kammler S; Scheid A; Schaal H
    Virology; 2001 Aug; 286(2):276-89. PubMed ID: 11485396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of HIV replication].
    Adachi A; Yamamoto Y; Sone S
    Uirusu; 1996 Dec; 46(2):145-54. PubMed ID: 9123886
    [No Abstract]   [Full Text] [Related]  

  • 16. Human immunodeficiency virus type 1 Tat increases the expression of cleavage and polyadenylation specificity factor 73-kilodalton subunit modulating cellular and viral expression.
    Calzado MA; Sancho R; Muñoz E
    J Virol; 2004 Jul; 78(13):6846-54. PubMed ID: 15194760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV trans-activation and transcription control mechanisms.
    Jones KA
    New Biol; 1989 Nov; 1(2):127-35. PubMed ID: 2562218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.
    Pearson L; Garcia J; Wu F; Modesti N; Nelson J; Gaynor R
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5079-83. PubMed ID: 2195547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Merged screening for human immunodeficiency virus Tat and Rev inhibitors.
    Hamy F; Felder E; Lipson K; Klimkait T
    J Biomol Screen; 2001 Jun; 6(3):179-87. PubMed ID: 11689114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination gene therapy: synergistic inhibition of human immunodeficiency virus Tat and Rev functions by a single RNA molecule.
    Lisziewicz J; Zeng G; Gratas C; Weinstein JN; Lori F
    Hum Gene Ther; 2000 Apr; 11(6):807-15. PubMed ID: 10779158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.